相关实验视频
Updated: Jul 28, 2025

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
758
关于当代管理常见良性肺溢的专家评价
1Pleural Medicine Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, IRBLleida, University of Lleida, Lleida, Spain.
Seminars in respiratory and critical care medicine
|June 1, 2023
概括
心力衰竭和肝硬化通常会导致膜溢出,这表明疾病已经晚了. 治疗策略有所不同,包括针对心力衰竭的特定药物和针对肝脏胸水和结核病的谨慎药物选择.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
背景情况:
- 胸腔溢出 (PE) 在心力衰竭 (HF) 和肝硬化中很常见,通常标志着晚期疾病和不良预后.
- 优化与HF相关的输液和肝脏水胸 (HH) 的医疗治疗需要超出利尿剂的量身定制的药理学方法.
- 肺结核 (TB) 仍然是一个重大的健康问题,特别是在发展中国家,由于其肺结核性质,诊断存在挑战.
研究的目的:
- 审查和综合目前与心力衰竭,肝硬化和肺结核相关的肺流的管理策略.
- 要突出与HH相关的PEs与HH相关的PEs的药理疗法的细微差别.
- 讨论耐火性PE的干预程序和先进疗法,以及对多发性结核病的诊断考虑.
主要方法:
- 对当前的指导方针和临床实践的文献综述,用于管理HF,肝硬化和结核病中的肺.
- 对药理治疗选择的分析,包括利尿剂,特定的HF药物和对HH的禁忌.
- 评估干预程序,如治疗胸腔切除和内置性肺部导管 (IPCs),以及跨内肝移植系统 (TIPS) 在HH的作用.
主要成果:
- 肝炎患者可以从特定的药物中获益,如血管新生素受体-尼普利辛抑制剂,β 阻断剂,矿物质皮质体受体对抗剂和SGLT2抑制剂;非选择性β 阻断剂应避免在肝炎中使用.
- 耐火性PEs是通过胸腔切除或IPC来管理的; TIPS被认为是用于抗利尿剂/不易治疗的HH,作为移植的桥梁.
- 随着核酸放大测试,肺结核的诊断得到了改善,治疗遵循肺结核的指导方针,考虑到艾滋病毒共感染患者的药物相互作用.
结论:
- 量身定制的医疗和干预策略对于在心力衰竭和肝硬化中管理腹腔液至关重要,这显著影响了患者的预后.
- 内置性肺结核导管和TIPS为耐火病例提供了有价值的选择,而对药物相互作用的仔细考虑对于肺结核管理至关重要,特别是在同时感染的患者中.
相关概念视频
Pleural Effusion II: Symptoms and Management
223
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
223
Pleural Effusion I: Introduction
1.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.3K
Pneumothorax-II
222
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
222
Pleural Disorders: Types and Brief Description
252
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
252
Pleura of the Lungs
2.4K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.4K
Pericarditis III: Medical Management
17
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
17

